Effects of ipragliflozin, a selective sodium–glucose co-transporter 2 inhibitor, on blood pressure in Japanese patients with type 2 diabetes mellitus: a pooled analysis of six randomized, placebo-controlled clinical trials

Our aim was to examine the effects of ipragliflozin, a selective sodium–glucose co-transporter 2 inhibitor, on blood pressure in Japanese patients with type 2 diabetes mellitus (T2DM). We conducted a pooled analysis of double-blind trials of Japanese T2DM patients, randomized to 50 mg ipragliflozin...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Diabetol Int
Asıl Yazarlar: Kashiwagi, Atsunori, Yoshida, Satoshi, Kawamuki, Kosei, Nakamura, Ichiro, Kazuta, Kenichi, Ueyama, Eiji, Takahashi, Hideyuki, Akiyama, Noriko, Kondo, Yoshinori, Ogihara, Toshio
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Springer Japan 2016
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6224932/
https://ncbi.nlm.nih.gov/pubmed/30603310
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13340-016-0283-x
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller